vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.
OPEN TEXT CORP is the larger business by last-quarter revenue ($1.3B vs $950.5M, roughly 1.4× Astrana Health, Inc.). OPEN TEXT CORP runs the higher net margin — 12.7% vs 0.7%, a 12.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -0.6%). OPEN TEXT CORP produced more free cash flow last quarter ($279.4M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -4.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Open Text Corporation is a global software company that develops and sells information management software.
ASTH vs OTEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.3B |
| Net Profit | $6.6M | $168.1M |
| Gross Margin | — | 74.0% |
| Operating Margin | 1.9% | 22.0% |
| Net Margin | 0.7% | 12.7% |
| Revenue YoY | 42.9% | -0.6% |
| Net Profit YoY | 184.4% | -26.9% |
| EPS (diluted) | $0.12 | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.3B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.4B | ||
| Q1 24 | $404.4M | $1.4B |
| Q4 25 | $6.6M | $168.1M | ||
| Q3 25 | $373.0K | $146.6M | ||
| Q2 25 | $9.4M | $28.8M | ||
| Q1 25 | $6.7M | $92.8M | ||
| Q4 24 | $-7.8M | $229.9M | ||
| Q3 24 | $16.1M | $84.4M | ||
| Q2 24 | $19.2M | $248.2M | ||
| Q1 24 | $14.8M | $98.3M |
| Q4 25 | — | 74.0% | ||
| Q3 25 | — | 72.8% | ||
| Q2 25 | — | 72.3% | ||
| Q1 25 | — | 71.6% | ||
| Q4 24 | — | 73.3% | ||
| Q3 24 | — | 71.7% | ||
| Q2 24 | — | 72.5% | ||
| Q1 24 | — | 73.0% |
| Q4 25 | 1.9% | 22.0% | ||
| Q3 25 | 2.0% | 21.0% | ||
| Q2 25 | 3.1% | 13.9% | ||
| Q1 25 | 3.3% | 16.7% | ||
| Q4 24 | 0.1% | 22.2% | ||
| Q3 24 | 5.9% | 16.3% | ||
| Q2 24 | 6.2% | 14.2% | ||
| Q1 24 | 7.5% | 15.7% |
| Q4 25 | 0.7% | 12.7% | ||
| Q3 25 | 0.0% | 11.4% | ||
| Q2 25 | 1.4% | 2.2% | ||
| Q1 25 | 1.1% | 7.4% | ||
| Q4 24 | -1.2% | 17.2% | ||
| Q3 24 | 3.4% | 6.6% | ||
| Q2 24 | 3.9% | 18.2% | ||
| Q1 24 | 3.7% | 6.8% |
| Q4 25 | $0.12 | $0.66 | ||
| Q3 25 | $0.01 | $0.58 | ||
| Q2 25 | $0.19 | $0.11 | ||
| Q1 25 | $0.14 | $0.35 | ||
| Q4 24 | $-0.14 | $0.87 | ||
| Q3 24 | $0.33 | $0.32 | ||
| Q2 24 | $0.40 | $0.91 | ||
| Q1 24 | $0.31 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $1.3B |
| Total DebtLower is stronger | — | $6.4B |
| Stockholders' EquityBook value | $779.3M | $4.0B |
| Total Assets | $2.2B | $13.6B |
| Debt / EquityLower = less leverage | — | 1.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $1.3B | ||
| Q3 25 | $463.4M | $1.1B | ||
| Q2 25 | $342.1M | $1.2B | ||
| Q1 25 | $260.9M | $1.3B | ||
| Q4 24 | $290.8M | $1.1B | ||
| Q3 24 | $350.3M | $1.0B | ||
| Q2 24 | $327.7M | $1.3B | ||
| Q1 24 | $337.3M | $1.1B |
| Q4 25 | — | $6.4B | ||
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | — | $6.4B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.4B | ||
| Q1 24 | — | $8.4B |
| Q4 25 | $779.3M | $4.0B | ||
| Q3 25 | $775.5M | $4.0B | ||
| Q2 25 | $765.5M | $3.9B | ||
| Q1 25 | $745.4M | $4.1B | ||
| Q4 24 | $712.7M | $4.2B | ||
| Q3 24 | $704.6M | $4.1B | ||
| Q2 24 | $678.9M | $4.2B | ||
| Q1 24 | $653.5M | $4.1B |
| Q4 25 | $2.2B | $13.6B | ||
| Q3 25 | $2.2B | $13.5B | ||
| Q2 25 | $1.4B | $13.8B | ||
| Q1 25 | $1.3B | $13.8B | ||
| Q4 24 | $1.4B | $13.7B | ||
| Q3 24 | $1.3B | $13.8B | ||
| Q2 24 | $1.3B | $14.2B | ||
| Q1 24 | $1.2B | $16.4B |
| Q4 25 | — | 1.58× | ||
| Q3 25 | — | 1.61× | ||
| Q2 25 | — | 1.62× | ||
| Q1 25 | — | 1.55× | ||
| Q4 24 | — | 1.51× | ||
| Q3 24 | — | 1.55× | ||
| Q2 24 | — | 1.52× | ||
| Q1 24 | — | 2.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $318.7M |
| Free Cash FlowOCF − Capex | $-6.0M | $279.4M |
| FCF MarginFCF / Revenue | -0.6% | 21.1% |
| Capex IntensityCapex / Revenue | 0.3% | 3.0% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.90× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $878.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $318.7M | ||
| Q3 25 | $10.0M | $147.8M | ||
| Q2 25 | $90.9M | $158.2M | ||
| Q1 25 | $16.6M | $402.2M | ||
| Q4 24 | $-10.9M | $348.0M | ||
| Q3 24 | $34.0M | $-77.8M | ||
| Q2 24 | $23.2M | $185.2M | ||
| Q1 24 | $6.0M | $384.7M |
| Q4 25 | $-6.0M | $279.4M | ||
| Q3 25 | $7.4M | $101.2M | ||
| Q2 25 | $89.5M | $124.0M | ||
| Q1 25 | $13.6M | $373.8M | ||
| Q4 24 | $-13.5M | $306.7M | ||
| Q3 24 | $31.7M | $-117.1M | ||
| Q2 24 | $20.4M | $145.2M | ||
| Q1 24 | $5.6M | $348.2M |
| Q4 25 | -0.6% | 21.1% | ||
| Q3 25 | 0.8% | 7.9% | ||
| Q2 25 | 13.7% | 9.5% | ||
| Q1 25 | 2.2% | 29.8% | ||
| Q4 24 | -2.0% | 23.0% | ||
| Q3 24 | 6.6% | -9.2% | ||
| Q2 24 | 4.2% | 10.7% | ||
| Q1 24 | 1.4% | 24.1% |
| Q4 25 | 0.3% | 3.0% | ||
| Q3 25 | 0.3% | 3.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.5% | 2.3% | ||
| Q4 24 | 0.4% | 3.1% | ||
| Q3 24 | 0.5% | 3.1% | ||
| Q2 24 | 0.6% | 2.9% | ||
| Q1 24 | 0.1% | 2.5% |
| Q4 25 | -0.44× | 1.90× | ||
| Q3 25 | 26.69× | 1.01× | ||
| Q2 25 | 9.65× | 5.49× | ||
| Q1 25 | 2.48× | 4.33× | ||
| Q4 24 | — | 1.51× | ||
| Q3 24 | 2.11× | -0.92× | ||
| Q2 24 | 1.21× | 0.75× | ||
| Q1 24 | 0.40× | 3.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
OTEX
| Transferred At Point In Time | $184.2M | 14% |
| Cybersecurity Enterprise Product | $174.5M | 13% |
| Business Network Product | $159.8M | 12% |
| Business Network Cloud Services And Subscriptions | $151.4M | 11% |
| Content Cloud Services And Subscriptions | $137.9M | 10% |
| Cybersecurity SMB Consumer Product | $127.6M | 10% |
| Application Delivery Management Product | $120.1M | 9% |
| IT Operations Management Product | $113.3M | 9% |
| Professional Service And Other | $82.5M | 6% |
| Analytics Product | $58.1M | 4% |
| IT Operations Management Cloud Services And Subscriptions | $7.8M | 1% |
